Fumaric Acid

Fumaric Acid

SCHEMBL6522397

CN(CCO)CCCOCCc1ccc2sccc2c1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 1/20 0.33
SIGMAR1 Q99720 3/20 0.60
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36
LSS P48449 3/20 0.36
CYP2A6 P11509 1/20 0.34
LTA4H P09960 3/20 0.34
MRGPRX4 Q96LA9 1/20 0.32
CTNNB1 P35222 1/20 0.32
WNT3A P56704 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6522403 1.00 SIGMAR1 (0.60) SIGMAR1OPRM1OPRK1LSSCYP2A6
Fumaric Acid SCHEMBL3811781 0.94 SIGMAR1 (0.57) SIGMAR1OPRM1OPRK1LSSCYP2A6
Fumaric Acid SCHEMBL3811775 0.94 SIGMAR1 (0.57) SIGMAR1OPRM1OPRK1LSSCYP2A6
Oxalic Acid SCHEMBL3807802 0.93 SIGMAR1 (0.51) SIGMAR1OPRM1OPRK1CYP2A6LTA4H
SCHEMBL27091 0.92 SIGMAR1 (0.55) SIGMAR1OPRM1OPRK1CYP2A6LTA4H
Oxalic Acid SCHEMBL3811633 0.89 SIGMAR1 (0.49) SIGMAR1OPRM1OPRK1LSSCYP2A6
SCHEMBL3811870 0.87 SIGMAR1 (0.53) SIGMAR1OPRM1OPRK1LSSCYP2A6
Oxalic Acid SCHEMBL3807582 0.86 SIGMAR1 (0.48) SIGMAR1OPRM1OPRK1CYP2A6MRGPRX4
SCHEMBL3807910 0.85 SIGMAR1 (0.51) SIGMAR1OPRM1OPRK1CYP2A6
Oxalic Acid SCHEMBL3808414 0.85 SIGMAR1 (0.48) SIGMAR1OPRM1OPRK1CYP2A6LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050250843-A1 Medicinal compositions improving brain function and method for improving brain function TOYAMA CHEMICAL CO., LTD. (JP) 2005-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250843-A1 Medicinal compositions improving brain function and method for improving brain function CHRM2, ACHE, CHAT HRH1 804/4885SIGMAR1 1872/4885OPRM1 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.